IRCT20200407046981N20Not yet recruiting未知
Comparative bioequivalence study of the Omeprazole 10-mg Sachet manufactured by Kimia Kala Razi Pharmaceutical Company versus Nexium® (AstraZeneca Company)
Kimia Kala Razi Pharmaceutical Company0 sites24 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 60 years (—)
- Sex
- Male
Inclusion Criteria
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form.
Exclusion Criteria
- •Known hypersensitivity or idiosyncratic reaction to omeprazole or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two weeks before dosing.
Investigators
Similar Trials
Recruiting
Not Applicable
Study of absorption and elimination rate of omeprazole 20 mg capsule in comparison with omeprazole brand capsules (Prilosec®).bioequivalence study.IRCT20200407046981N19Yas Kavir Meybod Pharmaceutical Company24
Completed
Not Applicable
Comparative bioequivalence study of the Omeprazole 10-mg Sachet manufactured by Nafas Zist Pharmed Pharmaceutical CompanyIRCT20130313012810N9afas Zist Pharmed Pharmaceutical Company24
Recruiting
Unknown
Investigating bioequivalence of Omeprazole capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N16Tabriz University of Medical Sciences24
Not yet recruiting
Not Applicable
The comparison of the efficacy of two therapeutic regimens in the treatment of gastroesophageal reflux disease in term neonates.IRCT20160827029535N10Tehran University of Medical Sciences120
Completed
Not Applicable
Bioequivalance study of Omeprazole 20mgIRCT20200513047423N2Sina Pishgam Darou Novin24